2026 Global: Automation Control In Medical Devices Market -Competitive Review (2032) report
Description
The 2026 Global: Automation Control In Medical Devices Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Siemens Healthineers, headquartered in Erlangen, Germany, is a leading provider of imaging, diagnostics, and automation solutions that integrate control systems across hospital networks and radiology workflows. Philips, headquartered in Amsterdam, Netherlands, advances automated patient monitoring, imaging, and clinical decision support platforms designed to optimize throughput and reduce operator variability. GE Healthcare, based in Chicago, United States, delivers automation-enabled medical imaging, diagnostics, and digital health ecosystems that connect devices with cloud analytics and AI-driven decision support. Medtronic, headquartered in Dublin, Ireland, applies automation and telemetry in therapy delivery systems, from automated drug infusion to remotely monitored implanted devices, integrating control algorithms with patient data streams. Together these firms set standards for interoperability, cybersecurity, and scalable control architectures that underpin modern medical devices and connected care, shaping the competitive landscape for OEMs and hospital systems alike. These dynamics drive investment in standards, data security, and seamless device integration across care delivery today.
Abbott Laboratories, headquartered in Abbott Park, United States, is a diversified medical-device and diagnostics company whose automation capabilities span high-throughput laboratory instrumentation, integrated data systems, and workflow management platforms used in clinical settings. Stryker, headquartered in Kalamazoo, United States, is a producer of surgical robotics and implant systems, where control software coordinates imaging, navigation, and instrument actuation to improve precision. Boston Scientific, based in Marlborough, United States, sells devices with integrated sensors, telemetry interfaces, and automated procedural workflows that streamline operating room throughput. Edwards Lifesciences, headquartered in Irvine, United States, focuses on automated hemodynamic monitoring and percutaneous interventional devices that rely on precise control of flow, pressure, and telemetry, enabling real-time data capture and decision support. Together these companies drive standardization in data interoperability, safety validation, and scalable automation across procedural platforms and patient care settings and industry standards. These capabilities underpin automation across hospital laboratories, clinics, and point-of-care settings.
Terumo Corporation, headquartered in Tokyo, Japan, manufactures cardiovascular products, infusion systems, and interventional devices that integrate automated control and monitoring features to support precise dosing, flow management, and patient safety. BD (Becton Dickinson), headquartered in Franklin Lakes, United States, provides automated specimen processing, blood collection, and diagnostic instruments that leverage robotics, automation software, and data connectivity to enable high-throughput workflows. These capabilities underpin scalable automation across hospital laboratories, clinics, and point-of-care settings. As such, these firms contribute to efficiency, accuracy, and safety by embedding autonomous features within devices, enabling remote monitoring and data-driven decision making. Their market presence reinforces cross sector collaboration to standardize interfaces and ensure cybersecurity across automated medical technologies. Continued investment in training and validation supports regulatory approvals and adoption in diverse care settings. These developments position Terumo and BD as essential components of automated clinical workflows. Their global reach supports standardized protocols and scalable deployment worldwide.
Siemens Healthineers, headquartered in Erlangen, Germany, is a leading provider of imaging, diagnostics, and automation solutions that integrate control systems across hospital networks and radiology workflows. Philips, headquartered in Amsterdam, Netherlands, advances automated patient monitoring, imaging, and clinical decision support platforms designed to optimize throughput and reduce operator variability. GE Healthcare, based in Chicago, United States, delivers automation-enabled medical imaging, diagnostics, and digital health ecosystems that connect devices with cloud analytics and AI-driven decision support. Medtronic, headquartered in Dublin, Ireland, applies automation and telemetry in therapy delivery systems, from automated drug infusion to remotely monitored implanted devices, integrating control algorithms with patient data streams. Together these firms set standards for interoperability, cybersecurity, and scalable control architectures that underpin modern medical devices and connected care, shaping the competitive landscape for OEMs and hospital systems alike. These dynamics drive investment in standards, data security, and seamless device integration across care delivery today.
Abbott Laboratories, headquartered in Abbott Park, United States, is a diversified medical-device and diagnostics company whose automation capabilities span high-throughput laboratory instrumentation, integrated data systems, and workflow management platforms used in clinical settings. Stryker, headquartered in Kalamazoo, United States, is a producer of surgical robotics and implant systems, where control software coordinates imaging, navigation, and instrument actuation to improve precision. Boston Scientific, based in Marlborough, United States, sells devices with integrated sensors, telemetry interfaces, and automated procedural workflows that streamline operating room throughput. Edwards Lifesciences, headquartered in Irvine, United States, focuses on automated hemodynamic monitoring and percutaneous interventional devices that rely on precise control of flow, pressure, and telemetry, enabling real-time data capture and decision support. Together these companies drive standardization in data interoperability, safety validation, and scalable automation across procedural platforms and patient care settings and industry standards. These capabilities underpin automation across hospital laboratories, clinics, and point-of-care settings.
Terumo Corporation, headquartered in Tokyo, Japan, manufactures cardiovascular products, infusion systems, and interventional devices that integrate automated control and monitoring features to support precise dosing, flow management, and patient safety. BD (Becton Dickinson), headquartered in Franklin Lakes, United States, provides automated specimen processing, blood collection, and diagnostic instruments that leverage robotics, automation software, and data connectivity to enable high-throughput workflows. These capabilities underpin scalable automation across hospital laboratories, clinics, and point-of-care settings. As such, these firms contribute to efficiency, accuracy, and safety by embedding autonomous features within devices, enabling remote monitoring and data-driven decision making. Their market presence reinforces cross sector collaboration to standardize interfaces and ensure cybersecurity across automated medical technologies. Continued investment in training and validation supports regulatory approvals and adoption in diverse care settings. These developments position Terumo and BD as essential components of automated clinical workflows. Their global reach supports standardized protocols and scalable deployment worldwide.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
